N A Day
Overview
Explore the profile of N A Day including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
369
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fahey A, Day N, GELBER H
J Telemed Telecare
. 2003 Apr;
9(2):84-8.
PMID: 12699577
We developed a tele-education programme in child mental health for rural allied health workers. The programme was delivered in two parts, each consisting of six sessions. Videoconferencing at 384 kbit/s...
2.
A comparison of the Assessment of Quality of Life (AQoL) with four other generic utility instruments
Hawthorne G, Richardson J, Day N
Ann Med
. 2001 Aug;
33(5):358-70.
PMID: 11491195
As part of the validation of the Assessment of Quality of Life (AQoL) instrument comparisons were made between five multiattribute utility (MAU) instruments, each purporting to measure health-related quality of...
3.
4.
Linebaugh B, Sameni M, Day N, Sloane B, Keppler D
Eur J Biochem
. 1999 Aug;
264(1):100-9.
PMID: 10447678
Lysosomal cathepsin B has been implicated in parasitic, inflammatory and neoplastic diseases. Most of these pathologies suggest a role for cathepsin B outside the cells, although the origin of extracellular...
5.
Moin K, Cao L, Day N, Koblinski J, Sloane B
Biol Chem
. 1998 Oct;
379(8-9):1093-9.
PMID: 9792442
The lysosomal cysteine peptidase cathepsin B was found to be associated with plasma membrane/endosomal fractions of murine B16 amelanotic melanoma cells. Confocal microscopy with three dimensional image analysis indicated that...
6.
Ren W, Fridman R, Zabrecky J, Morris L, Day N, Sloane B
Biochem J
. 1996 Nov;
319 ( Pt 3):793-800.
PMID: 8920982
Cathepsin B has been implicated in numerous pathobiological processes. In order to study its interactions with other proteins implicated in these processes, quantities of functional recombinant cathepsin B are needed....
7.
Moin K, Day N, Sameni M, Hasnain S, Hirama T, Sloane B
Biochem J
. 1992 Jul;
285 ( Pt 2):427-34.
PMID: 1637335
Cathepsin B was purified from normal human liver and several human tumour tissues and partially characterized. Three forms of cathepsin B, with molecular masses of 25 kDa, 26 kDa (the...
8.
Buck M, Karustis D, Day N, Honn K, Sloane B
Biochem J
. 1992 Feb;
282 ( Pt 1):273-8.
PMID: 1540143
Our laboratory has previously demonstrated that increased malignancy of several histological types of human and animal tumours is associated with increases in their cathepsin B activity, particularly cathepsin B activity...
9.
Lah T, Clifford J, Helmer K, Day N, Moin K, Honn K, et al.
Biochim Biophys Acta
. 1989 Oct;
993(1):63-73.
PMID: 2804124
Elevated activities of cysteine proteinases such as cathepsins B and L and cancer procoagulant have been linked to tumor malignancy. In the present study we examined the hypothesis that these...
10.
Day N, Deslondes J, Nelson M
J Psychoactive Drugs
. 1988 Apr;
20(2):179-83.
PMID: 3418450
No abstract available.